Endothelium-Derived Relaxing Factor Produced and Released From

Endothelium-Derived Relaxing Factor Produced and Released From

Proc. Natl. Acad. Sci. USA Vol. 84, pp. 9265-9269, December 1987 Medical Sciences Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide (endothelium-dependent relaxation/vascular smooth muscle/cyclic GMP) Louis J. IGNARRO*t, GEORGETTE M. BUGA*, KEITH S. WOOD*, RUSSELL E. BYRNS*, AND GAUTAM CHAUDHURIt Departments of *Pharmacology and tObstetrics and Gynecology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90024 Communicated by C. H. Sawyer, August 31, 1987 ABSTRACT The objective of this study was to determine guanylate cyclase (7). Similar observations were made by whether nitric oxide (NO) is responsible for the vascular others (21, 22). In studies designed to compare the actions of smooth muscle relaxation elicited by endothelium-derived EDRF and NO in artery and vein, we found that EDRF and relaxing factor (EDRF). EDRF is an unstable humoral sub- NO possessed virtually indistinguishable properties and hy- stance released from artery and vein that mediates the action pothesized that EDRF is NO§ (23, 24). A similar hypothesis of endothelium-dependent vasodilators. NO is an unstable based on experiments of a different experimental design was endothelium-independent vasodilator that is released from recently advanced (25). The objective of the present study vasodilator drugs such as nitroprusside and glyceryl trinitrate. was to compare more closely the biological and chemical We have repeatedly observed that the actions ofNO on vascular properties of NO to those of EDRF released from perfused smooth muscle closely resemble those of EDRF. In the present artery, vein, and freshly isolated aortic endothelial cells and study the vascular effects of EDRF released from perfused to ascertain chemically whether EDRF and NO are the same bovine intrapulmonary artery and vein were compared with substance. During the preparation ofthis manuscript a report the effects of NO delivered by superfusion over endothelium- appeared confirming the biological and chemical identifica- denuded arterial and venous strips arranged in a cascade. tion of EDRF released from cultured endothelial cells as NO EDRF was indistinguishable from NO in that both were labile (26). (1i/2 = 3-5 sec), inactivated by pyrogallol or superoxide anion, stabilized by superoxide dismutase, and inhibited by oxyhe- AND moglobin or potassium. Both EDRF and NO produced com- MATERIALS METHODS parable increases in cyclic GMP accumulation in artery and Reagents. Acetylcholine chloride, phenylephrine hydro- vein, and this cyclic GMP accumulation was inhibited by chloride, A23187, pyrogallol, hemoglobin (human), and su- pyrogallol, oxyhemoglobin, potassium, and methylene blue. peroxide dismutase (bovine liver) were obtained from Sigma. EDRF was identified chemically as NO, or a labile nitroso Glyceryl trinitrate (10% wt/wt triturate in lactose) was a gift species, by two procedures. First, like NO, EDRF released from Imperial Chemical Industries (Macclesfield, England), from freshly isolated aortic endothelial cells reacted with and propylbenzylylcholine mustard was provided by the hemoglobin to yield nitrosylhemoglobin. Second, EDRF and National Institute for Medical Research (Mill Hill, London). NO each similarly promoted the diazotization of sulfanilic acid NO (99o pure) was obtained from Matheson. A saturated and yielded the same reaction product after coupling with solution of NO (1-2 mM) in oxygen-free water (prepared by N-(1-naphthyl)-ethylenediamine. Thus, EDRF released from vacuum evacuation and nitrogen flushing) was prepared by artery and vein possesses identical biological and chemical injecting about 50 ml of NO gas into 2 ml of water contained properties as NO. in a small tube fitted with an air-tight serum cap through which syringe needles can be inserted for delivery and escape Both artery and vein are capable of releasing endothelium- of gases. Appropriate dilutions were similarly made in oxy- derived relaxing factor (EDRF) in response to chemically gen-free water with the aid of Hamilton gas-tight syringes. diverse vasodilators (1-9). Endothelium-dependent relax- NO concentrations are approximate and are based on a ation of artery and vein appears to be mediated by increases starting stock NO concentration of 1-2 mM. Solutions of NO in tissue cyclic GMP levels (10-13), and such effects are prepared in this manner were stable for several hours. inhibited by methylene blue, hemoglobin, and myoglobin Deoxyhemoglobin was prepared from hemoglobin by reduc- (13-15). Nitroso compounds, organic nitrate and nitrite tion with dithionite in deoxygenated Krebs-bicarbonate so- esters, and inorganic nitrite cause vascular smooth muscle lution (27). relaxation and cyclic GMP accumulation by endothelium- Bioassay Cascade Superfusion Technique. The details ofthis independent mechanisms, and these actions are attributed to procedure have been described previously (9) and represent the release a modification of the original procedure described by Vane of nitric oxide (NO) (16-19). NO itself is a labile (28). Briefly, segments of main bovine intrapulmonary artery substance that causes transient relaxation and cyclic GMP and vein were perfused (3.5 ml/min) with oxygenated Krebs- accumulation in both artery and vein (16-20). Moreover, NO bicarbonate solution at 37°C. The perfusate was allowed to directly activates soluble guanylate cyclase from vascular superfuse three isolated, helically cut, precontracted strips of smooth muscle, and the effects of NO are inhibited by endothelium-denuded artery (4 g of tension) or vein (2 g of methylene blue and hemoproteins (16-20). tension) arranged in a cascade (mounted independently one Thus, EDRF and NO possess very similar biological and on top of another) at 37°C. In addition, vascular strips were chemical properties. We also reported that arterial and superfused (3.5 ml/min) at 37°C from a separate line. Vas- venous EDRF, like NO, directly activates purified soluble Abbreviation: EDRF, endothelium-derived relaxing factor. The publication costs of this article were defrayed in part by page charge tTo whom reprint requests should be addressed. payment. This article must therefore be hereby marked "advertisement" §Invited presentation of the Fourth Symposium on Mechanisms of in accordance with 18 U.S.C. §1734 solely to indicate this fact. Vasodilatation, July 11, 1986, Rochester, MN. 9265 Downloaded by guest on September 26, 2021 9266 Medical Sciences: Ignarro et al. Proc. Natl. Acad. Sci. USA 84 (1987) cular strips were precontracted by 10 ,uM phenylephrine was added. After 30 min, 4 ml was transferred to a cuvette, (artery) or 0.01 ,uM U46619 (vein) delivered by superfusion. and the absorbance at 548 nm was measured. Changes in tension were monitored and recorded as de- scribed (9). Perfusion and superfusion media contained 10 ,M indomethacin to prevent prostaglandin formation, and in RESULTS experiments employing acetylcholine, arterial strips were Similarity of EDRF and NO in Bioassay Cascade Superfu- pretreated with 0.01 AM propylbenzylylcholine mustard to sion. Perfusion of an endothelium-intact segment of artery or prevent the direct contractile effects of acetylcholine (8, 9). vein caused small relaxant responses in the first two of three Glyceryl trinitrate, a stable endothelium-independent vaso- vascular strips arranged in cascade (Fig. 1). Arterial or dilator, was superfused over the strips in order to standardize venous perfusion with acetylcholine or A23187, respectively, the preparations (9, 29). In some experiments only one (Fig. caused further relaxation of the three strips. The decrement 3) or two (Fig. 2), rather than three, vascular strips were in magnitudes of relaxation down the cascade of strips is superfused. attributed to the very short half-life Isolation of Aortic Endothelial Cells. Bovine aortic endo- of EDRF released from thelial cells were isolated by a collagenase digestion proce- artery and vein. The approximate half-life of arterial and dure as described previously (30, 31). Fresh segments of venous EDRF was calculated from the tracings (Fig. 1) and bovine thoracic aorta were rinsed and treated with 0.2% found to be 3-5 sec. This was identical to that observed with (wt/vol) collagenase (protease-free) in phosphate-buffered NO, which was superfused directly over the vascular strips saline (pH 7.6) at 370C as described (30, 31). Isolated cells (Fig. 1). Direct superfusion of acetylcholine or A23187 over were suspended in Krebs-bicarbonate solution (degassed the strips produced no responses. Pyrogallol, which gener- under vacuum) to yield approximately 2 x 106 endothelial ates superoxide anion from oxygen-containing solutions (33), cells per ml and were used within 30 min. inhibited the relaxant actions of EDRF and NO, whereas Reactions Between Hemoglobin and EDRF or NO. Solutions superoxide dismutase enhanced and prolonged such relaxant of 5 ,M deoxyhemoglobin in Krebs-bicarbonate medium responses (Fig. 1). The chemical stability of both EDRF and buffered to pH 7.4 with 25 mM Tris HCl were prepared (4 ml) and scanned at 25°C (LKB Ultrospec II) under atmospheric conditions before and after addition ofNO. NO was delivered ArteryAePYRP | SOD | into cuvette solutions by slowly injecting 10 ml of NO gas directly into the solutions. NO caused a characteristic shift in the Soret absorbance peak of hemoglobin from 433 nm (£ = GTN Perf ACH NO ACH NO ACH NO 133 mM-1 cm-1) to 406 nm (E = 120 mM-1 cm-1). Aortic 1 1 4 endothelial cells (1 ml containing 106 cells) were added to 3 v _IX -I'I ml of 6.25 AM deoxyhemoglobin solution in the absence or x x presence of 1 ,M A23187. After the suspension was mixed 2 '- - gently for 90 sec at 25°C, the cell-free liquid component was -; k-- -il aspirated into a Pasteur pipet fitted at the tip with a small x j piece ofNytex nylon cloth to exclude the cells, transferred to 3 a cuvette, and scanned. Atmospheric oxygen did not interfere appreciably with the stabilities of either deoxyhemoglobin or nitrosylhemoglobin, in that no significant amounts of oxyhemoglobin (Soret peak: 416 nm) were detected under the Vein PYR SOD experimental conditions employed.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us